LABETALOL Safety Questions, LABETALOL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about LABETALOL. Our extensive database of LABETALOL adverse events and LABETALOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about LABETALOL
LABETALOL Safety Reports
Total LABETALOL reports: 9.LABETALOL FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 2.
Take LABETALOL Side Effects Survey or Share Your LABETALOL Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported LABETALOL problem on Jan 05, 2007. Female patient was diagnosed with hypertension and was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: chest pain, condition aggravated, dyspnoea exertional, economic problem, headache, hypertension, oedema peripheral, treatment noncompliance. LABETALOL dosage: 200 MG Q AM + 400 MG Q HS PO. During the same period patient was treated with FUROSEMIDE. Patient was hospitalized. Patient recovered.
LABETALOL problem was reported by a Physician from UNITED STATES on Feb 05, 2007. Female patient, 29 years of age, weighting 228.0 lb, was diagnosed with hypertension and was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, headache, nausea, vomiting. LABETALOL dosage: 200 MG # 2 BID ORAL. Patient recovered.
Physician from UNITED STATES reported LABETALOL problem on Feb 01, 2007. Female patient, 29 years of age, was treated with LABETALOL. LABETALOL dosage: unknown. Patient died.
LABETALOL problem was reported by a Pharmacist from UNITED STATES on Mar 19, 2007. Female patient, 77 years of age, was treated with LABETALOL. LABETALOL dosage: unknown. Patient died.
Pharmacist from UNITED STATES reported LABETALOL problem on May 30, 2007. Female patient, 63 years of age, weighting 197.5 lb, was diagnosed with hypertension and was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. LABETALOL dosage: unknown. Patient recovered.
LABETALOL problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Male patient, 80 years of age, weighting 149.7 lb, was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: bradycardia. LABETALOL dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported LABETALOL problem on Sept 12, 2006. Male patient, 63 years of age, weighting 280.0 lb, was diagnosed with hypertension and was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: respiratory disorder, swelling. LABETALOL dosage: 300 MG 2 X DAILY. Patient recovered.
LABETALOL problem was reported by a Pharmacist from UNITED STATES on Oct 12, 2006. Female patient, 68 years of age, was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: dyspnoea. LABETALOL dosage: 100MG X 1 DOSE IV BOLUS. During the same period patient was treated with FENTANYL CITRATE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported LABETALOL problem on Aug 31, 2007. Female patient, 48 years of age, was diagnosed with hypertension and was treated with LABETALOL. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, no therapeutic response. LABETALOL dosage: 5 MG, INTRAVENOUS; 10 MG/H, INFUSION. During the same period patient was treated with PHENOXYBENZAMINE, METOPROLOL TARTRATE, PROPOFOL, MIDAZOLAM, FENTANYL, VECURONIUM BROMIDE, BUPIVACAINE, MAGNESIUM. Patient recovered.